Haisco Pharmaceutical Group Co., Ltd.
002653
株式のランク
#2011
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
株価
$9.03
時価総額
$10.30B
変化（1日）
4.55%
変化（1年）
24.15%
国
CN
取引 Haisco Pharmaceutical Group Co., Ltd. (002653)
カテゴリー
Healthcare
Haisco Pharmaceutical Group Co., Ltd.（002653）の株式分割履歴
Haisco Pharmaceutical Group Co., Ltd.株（シンボル：002653）は合計で2回の株式分割を実施しました。
最新の株式分割はSep 12, 2013に行われました。
Mar 11, 2013より前に購入された002653株は、現在2.7002653株に相当します。
最新の株式分割はSep 12, 2013に行われました。
Mar 11, 2013より前に購入された002653株は、現在2.7002653株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 2013-09-12 | 27:20 | x1.35 | x2.7 |
| 2013-03-11 | 2:1 | x2 | x2 |
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
